查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929658

全球週边血分离管市场（按产品、技术、应用和最终用户划分）预测（2026-2032年）

Peripheral Blood Separation Tube Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年外周血分离管市场价值为 8.1412 亿美元，预计到 2026 年将增长至 8.7502 亿美元，预计到 2032 年将达到 12.7693 亿美元，复合年增长率为 6.64%。

主要市场统计数据
基准年 2025 8.1412亿美元
预计年份：2026年 8.7502亿美元
预测年份：2032年 1,276,930,000 美元
复合年增长率 (%) 6.64%

本文简要概述了影响週边血分离管生态系的临床意义、技术进步和运作重要性。

週边血分离管是临床诊断、输血医学和转化研究中的基础工具，是连接病患检体和下游检测流程的桥樑。这些分离管能够高效分离血浆、血清和细胞成分，同时保持分析物的完整性，适用于从常规血液学检测到先进细胞治疗流程的各种应用。随着临床通讯协定向更高通量和灵敏度发展，分离管的设计和性能特征，包括抗凝血剂的化学性质、分离技术和材料相容性，都成为决定诊断准确性和操作效率的关键因素。

临床需求、先进分离技术和供应链韧性的融合如何重塑产品预期和策略伙伴关係

由于临床、技术和操作因素的共同作用，週边血液分离管领域正经历变革性的转变。分离技术的进步，包括密度梯度分离、凝胶分离、膜分离系统和微流体平台，使得细胞分级分离的精确控制和生物标记保存的改善成为可能，从而促进了精准诊断和细胞疗法的广泛应用。随着检查室追求更高的自动化等级和更有效率的工作流程，分离管必须具备稳定可靠的自动化性能和严格的公差，最大限度地减少人工操作时间，并降低分析前误差。

评估2025年美国累积关税对该领域采购、製造本地化和采购韧性的系统性和营运性影响

2025年实施的累积关税标誌着週边血分离管价值链的筹资策略、製造地和定价趋势发生了关键性转变。进口关税的提高增加了从受影响地区采购的某些原材料和成品组件的到岸成本，迫使采购者重新评估总拥有成本（TCO），而不仅仅依赖单价比较。因此，采购团队在选择供应商时会考虑关税风险，并加强对原产地声明和关税分类的审查，以减少意外成本转嫁。

将终端用户画像、抗凝剂类型、应用、分离技术和分销管道与采购创新优先事项联繫起来的详细細項分析

这项富有洞察力的細項分析揭示了临床环境、产品形式、应用、技术和分销管道的差异如何影响週边血分离管的需求特征和实施重点。终端用户群十分多元化。血库包括私人和公共机构，它们优先考虑高通量处理和标准化，以确保输血安全。诊断实验室分为两类：一类是优先考虑临床工作流程和电子健康记录整合的医院检查室，另一类是优先考虑吞吐量和成本效益的独立检查室。医院包括诊所、二级医院和三级医院，每家医院的检测项目和后勤限制各不相同。就地检验中心既运作行动检测车，也运作固定检测中心，因此需要能够承受各种环境条件并实现快速处理的试管。研究机构涵盖从学术实验室到製药研发机构等各种类型，它们通常需要特殊的抗凝剂配方和分离技术，以保持细胞表型和功能，从而进行高级检测。

美洲、欧洲、中东、非洲和亚太地区监管严格程度、供应链策略和临床应用趋势的观点比较分析

区域趋势对週边血分离管的调节管道、供应链结构和临床应用模式有显着影响。在美洲，临床基​​础设施的特点是拥有完善的医院系统、广泛的实验室网络，并高度重视法规遵循和可追溯性。这种环境有利于那些具有可靠验证包装、与自动化平台相容且供应持续稳定的解决方案。采购团队优先考虑具有国内或区域生产能力的供应商，以最大限度地减少海关手续的复杂性，并支援大规模医院系统和血库的快速补货。

透过创新、监管能力和强大的生产基地实现差异化，以满足多样化的临床和研究需求。

週边血分离管领域的主要企业透过产品创新、严格的法规遵循和整合的供应链能力实现差异化竞争。市场参与企业涵盖了从跨国诊断和耗材製造商到专业利基生产商和契约製造组织 (CMO) 等各类企业，后者支援定製配方和自有品牌生产。竞争优势通常来自于将检验的品管生产能力与快速反应的技术支援和完善的上市后监管措施相结合。

在瞬息万变的医疗保健市场中，製造商和经销商可以采取哪些切实可行的策略步骤来增强产品差异化、供应链韧性和监管应对力？

在瞬息万变的市场环境中，产业领导者可以采取一系列切实可行的措施来巩固市场地位、提升产品价值并降低营运风险。首先，应优先考虑产品检验，并将其与临床工作流程和自动化测试系统结合。严格的性能演示和互通性测试将降低产品推广门槛，并有助于提升产品高端定位。其次，应增加对灵活製造和区域生产基地的投资，以减轻贸易中断的影响并满足区域监管要求。此外，还应制定清晰的品质系统协调计划，并在必要时进行重新认证。

整合永续竞争的策略要求：重点检验的临床价值、营运灵活性和监管合规性

週边血分离管在实验室操作、临床决策和转化研究的交会点占据着至关重要的地位。技术创新、临床工作流程的改变以及不断发展的贸易和法规环境的共同作用，正推动分析前设备从普通商品跃升为诊断和治疗领域的战略资产。医疗机构的选择标准也日益严格，优先考虑那些拥有检验的性能、监管能力和供应链韧性的供应商。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的周边血分离管市场

  • ACD管
    • ACD-A管
    • ACD-B管
  • 柠檬酸管
    • 柠檬酸钠管
    • 柠檬酸三钠管
  • EDTA管
    • K2 EDTA管
    • K3 EDTA管
  • 肝素管
    • 锂肝素管
    • 肝素钠管
  • 草酸管
    • 草酸钾管
    • 草酸钠管

9. 依技术分類的周边血分离管市场

  • 密度梯度离心
  • 凝胶分离管
  • 膜分离管
  • 微流体分离

第十章 依应用分類的周边血液分离管市场

  • 血库
  • 细胞疗法
  • 临床诊断
  • 研究

第十一章 依最终用户分類的外周血分离管市场

  • 血库
    • 私人血库
    • 公共血库
  • 诊断实验室
    • 医院检查室
    • 独立检验机构
  • 医院
    • 诊所
    • 二级护理医院
    • 三级医院
  • 就地检验中心
    • 移动式侦测单元
    • 现场测试中心
  • 研究所
    • 学术研究
    • 药物研究

第十二章 週边血分离管市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 週边血分离管市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国外周血分离管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 美国週边血分离管市场

第十七章 中国外周血分离管市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvaCare Pharma
  • Becton, Dickinson & Company
  • Biosigma SpA
  • Cardinal Health, Inc.
  • CML BIOTECH LIMITED
  • FL Medical SRL
  • Greiner Bio-One International GmbH
  • Haemonetics Corporation
  • Medtronic plc
  • Merck KGaA
  • Narang Medical Limited
  • Nipro Medical Corporation
  • QIAGEN NV
  • SARSTEDT AG & Co. KG
  • Sekisui Chemical Co., Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-0A3806951875

The Peripheral Blood Separation Tube Market was valued at USD 814.12 million in 2025 and is projected to grow to USD 875.02 million in 2026, with a CAGR of 6.64%, reaching USD 1,276.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 814.12 million
Estimated Year [2026] USD 875.02 million
Forecast Year [2032] USD 1,276.93 million
CAGR (%) 6.64%

A concise orientation to clinical relevance, technological evolution, and operational imperatives shaping the peripheral blood separation tube ecosystem

Peripheral blood separation tubes are foundational tools in clinical diagnostics, transfusion medicine, and translational research, serving as the interface between patient samples and downstream laboratory processes. These tubes facilitate efficient separation of plasma, serum, and cellular components while preserving analyte integrity for a broad range of applications from routine hematology to advanced cell therapy workflows. As clinical protocols evolve toward higher throughput and greater sensitivity, the design and performance characteristics of separation tubes-such as anticoagulant chemistry, separator technologies, and material compatibility-have become critical determinants of diagnostic fidelity and operational efficiency.

The contemporary landscape favors products that reduce pre-analytical variability, enhance sample stability, and integrate with automated systems. This creates pressure on suppliers to align manufacturing quality, regulatory documentation, and product portfolios with the increasingly rigorous needs of hospitals, reference laboratories, and research institutions. Concurrently, innovation in microfluidics and membrane-based separators is broadening the functional envelope of tubes, enabling more granular cell isolation and point-of-care workflows that previously required specialized instrumentation.

Against this backdrop, stakeholders must navigate shifting reimbursement environments, evolving regulatory expectations around labeling and biocompatibility, and the practical realities of global supply chains. The interplay of these elements shapes procurement criteria, informs product development roadmaps, and drives collaborations between clinical end users and manufacturers seeking to differentiate through validated performance and operational value.

How converging clinical demands, advanced separation technologies, and supply chain resilience are reshaping product expectations and strategic partnerships

The peripheral blood separation tube sector is undergoing transformative shifts driven by converging clinical, technological, and operational forces. Advances in separation technologies such as density gradient methods, gel-based separators, membrane systems, and microfluidic platforms are enabling finer control over cell fractionation and improved preservation of biomarkers, which in turn supports the rise of precision diagnostics and cell-based therapeutics. As laboratories pursue higher automation and leaner workflows, tubes must deliver consistent, automation-friendly performance and tighter tolerances to minimize hands-on time and reduce pre-analytical errors.

Clinical trends are reinforcing demand for robust pre-analytics: decentralized testing and point-of-care diagnostics are expanding the contexts in which tubes must perform reliably, while research and cell therapy applications require specialized anticoagulants and separation chemistries to maintain cell viability and functional integrity. These needs are accentuated by regulatory frameworks that increasingly emphasize traceability, material safety, and validation evidence, prompting manufacturers to invest in enhanced documentation and quality management systems.

Operationally, supply chain resilience and geographic diversification of production have become strategic priorities. Procurement teams are prioritizing suppliers with validated manufacturing controls, redundant sourcing, and transparent quality systems. Innovation ecosystems are also evolving, with collaborations between device makers, reagent suppliers, and clinical partners accelerating product iterations that address niche use cases, such as mobile testing units and pharmacological research applications. In sum, the landscape is shifting from commodity-driven procurement toward solution-oriented partnerships that emphasize validated performance, regulatory readiness, and supply continuity.

Assessment of the systemic and operational consequences of 2025 cumulative US tariffs on sourcing, manufacturing localization, and procurement resilience in the sector

The imposition of cumulative tariffs in the United States during 2025 has created a material inflection point for procurement strategies, manufacturing footprints, and pricing dynamics in the peripheral blood separation tube value chain. Increased import duties have elevated the landed cost of certain raw materials and finished components sourced from affected jurisdictions, prompting buyers to reassess total cost of ownership rather than relying solely on unit price comparisons. Consequently, procurement teams are factoring in tariff exposure when qualifying suppliers and are increasing scrutiny of origin declarations and tariff classifications to mitigate unexpected cost pass-throughs.

Manufacturers and contract producers have responded with a mix of tactical and strategic actions. Tactically, many have adjusted SKU mixes, negotiated alternative supplier contracts, and implemented cost-avoidance measures in procurement and logistics to absorb near-term tariff impacts without sacrificing quality. Strategically, several firms have accelerated localization plans, shifting critical production steps closer to key end markets or investing in regional manufacturing capabilities to reduce dependency on tariff-exposed supply lines. These investments improve responsiveness to demand variability and reduce vulnerability to future trade policy shifts, though they require capital, time, and regulatory re-certification efforts.

The tariffs have also influenced innovation trajectories. Developers are prioritizing material substitutions and design optimizations that maintain performance while reducing reliance on tariff-sensitive inputs. In parallel, end users have begun to factor tariff-induced lead-time variability into inventory policies and to consider longer procurement cycles with safety stock for essential consumables. Overall, the cumulative effect has been a rebalancing of cost, quality, and delivery considerations, with an emphasis on resilient sourcing, transparent supplier relationships, and product continuity under evolving trade conditions.

Detailed segmentation analysis connecting end-user profiles, anticoagulant types, applications, separation technologies, and distribution pathways to purchasing and innovation priorities

Insightful segmentation helps clarify how different clinical settings, product formats, applications, technologies, and distribution pathways shape demand characteristics and adoption priorities for peripheral blood separation tubes. End users vary widely: blood banks encompass private and public institutions that prioritize high-volume, standardized processing for transfusion safety, while diagnostic laboratories are split between hospital-based labs, which value integration with clinical workflows and electronic health records, and independent labs, which emphasize throughput and cost efficiency. Hospitals include clinics, secondary care hospitals, and tertiary care hospitals, each with distinct testing portfolios and logistical constraints. Point-of-care testing centers operate in both mobile testing units and on-site testing centers, requiring tubes that withstand varied environmental conditions and enable rapid processing. Research institutes span academic labs and pharmaceutical research facilities, often demanding specialized anticoagulant formulations and separator technologies to preserve cell phenotype and functionality for advanced assays.

Product-type differentiation is equally consequential: anticoagulant chemistries such as ACD, citrate, EDTA, heparin, and oxalate are chosen based on downstream analytical requirements and cell viability considerations. ACD variants, including ACD-A and ACD-B, are frequently specified for cell preservation in banking and therapy contexts, whereas citrate options like sodium citrate and trisodium citrate are selected when coagulation parameters are critical. EDTA in its K2 and K3 forms remains a mainstay for hematology due to its ability to chelate calcium without significantly altering cell morphology. Heparin tubes, available as lithium or sodium heparin, are favored for certain biochemical assays and for preserving cell function in operational workflows. Oxalate-based tubes, including potassium and sodium oxalate, remain relevant for specialized coagulation and biochemical testing where enzyme stability is a concern.

Application-driven needs further refine product selection: blood banking prioritizes donor safety and long-term stability, cell therapy requires formulations and separators that maintain viability and sterility, clinical diagnostics demand compatibility with analytic platforms and minimal pre-analytical variability, and research applications often need custom or small-batch solutions that support experimental protocols. Technological differentiation also plays a role: density gradient centrifugation is prized for its established role in mononuclear cell isolation, gel separator tubes provide simplified plasma/serum separation for routine testing, membrane separators offer selective filtering for targeted fractionation, and emerging microfluidic separation enables low-volume, high-precision isolation suitable for point-of-care and research contexts.

Distribution channels complete the segmentation picture by influencing procurement lead times, pricing models, and customer support expectations. Direct sales relationships are frequently preferred by large institutional buyers seeking contract terms and technical support, whereas distributors-operating through retailers and wholesalers-enable broader geographic reach and inventory coverage. Online retail, split between company websites and e-marketplaces, serves smaller buyers and enables rapid replenishment cycles. Each channel imposes different expectations around documentation, traceability, and post-sale service, which in turn affect supplier selection and product packaging decisions.

Comparative regional perspectives on regulatory rigor, supply chain strategies, and clinical adoption trends across the Americas, EMEA, and Asia-Pacific environments

Regional dynamics significantly influence regulatory pathways, supply chain architectures, and clinical adoption patterns for peripheral blood separation tubes. In the Americas, clinical infrastructures are characterized by advanced hospital systems, extensive laboratory networks, and a strong emphasis on regulatory compliance and traceability. This environment favors solutions with robust validation packages, compatibility with automated platforms, and supply continuity assurances. Procurement teams prioritize vendors with domestic or regional manufacturing capabilities to minimize customs complexity and to support rapid replenishment for large hospital systems and blood banks.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory regimes and healthcare capacities vary considerably. Western and parts of Northern Europe feature stringent regulatory oversight, well-established diagnostics networks, and a premium on product safety and environmental compliance. In contrast, regions across the Middle East and Africa often prioritize cost-effective, durable solutions that can tolerate wider logistical and environmental variability, while simultaneously encouraging local capacity building. For manufacturers, this region requires adaptable market strategies that combine compliance documentation for high-regulation markets with resilient distribution models for areas with limited cold-chain or logistical infrastructure.

Asia-Pacific encompasses a mix of mature markets with strong R&D ecosystems and high-volume manufacturing hubs, as well as rapidly developing healthcare systems experiencing growth in diagnostic capacity and translational research. Demand drivers in this region include investments in hospital modernization, expansion of point-of-care testing, and increased focus on cell therapy research. Manufacturers often leverage regional production capabilities to serve both domestic markets and export-oriented supply chains, while navigating diverse regulatory requirements and local preference for cost-competitive solutions. Across all regions, end users emphasize supply predictability, validated performance, and post-market support, but the weighting of these priorities shifts according to regional healthcare structures and procurement norms.

Corporate differentiation through innovation, regulatory competency, and resilient manufacturing footprints that support varied clinical and research demands

Leading companies in the peripheral blood separation tube domain are differentiating through product innovation, regulatory rigor, and integrated supply chain capabilities. Market participants range from multinational diagnostic and consumables manufacturers to specialized niche producers and contract manufacturing organizations that support tailored formulations and private-label production. The competitive edge often arises from the ability to combine validated, quality-managed manufacturing with responsive technical support and strong post-market surveillance practices.

Innovation pathways are clustered around anticoagulant chemistry optimization, separator material science, and platform compatibility. Firms investing in R&D to deliver microfluidic-enabled separation or enhanced membrane technologies can address emerging use cases such as low-volume point-of-care diagnostics and delicate cell therapy workflows. Equally important is regulatory competence: companies with established processes for device classification, biocompatibility testing, and clinical performance validation reduce adoption friction for institutional buyers. Strategic partnerships with clinical laboratories, research institutes, and automated instrument vendors also accelerate product validation and market acceptance.

Manufacturing footprint and supply chain architecture are further differentiators. Vendors with geographically diversified production and robust quality systems can better support large healthcare systems and blood banks that require reliable supply continuity. At the same time, contract manufacturers that offer small-batch flexibility and rapid development services enable researchers and niche clinical segments to access tailored solutions. Service and support capabilities-ranging from product training to troubleshooting for integration with robotic systems-reinforce customer retention and create opportunities for value-added offerings such as custom packaging, lot-level certificates, and inventory management programs.

Practical strategic steps for manufacturers and distributors to boost product differentiation, supply resilience, and regulatory readiness in a dynamic healthcare market

Industry leaders can adopt a set of actionable approaches to strengthen market position, enhance product value, and mitigate operational risks in a rapidly evolving environment. First, prioritize product validation that aligns with clinical workflows and automated laboratory systems; rigorous performance evidence and interoperability testing reduce adoption barriers and support premium positioning. Second, invest in flexible manufacturing and regional production nodes to reduce exposure to trade disruptions and to meet localized regulatory requirements; this approach should be coupled with a clear plan for quality system alignment and re-certification where necessary.

Third, pursue targeted innovation that addresses unmet needs such as low-volume microfluidic separation for point-of-care use, or anticoagulant formulations optimized for cell therapy and biologic research. These innovations should be developed in partnership with end users-blood banks, hospital labs, point-of-care centers, and research institutions-to accelerate validation and ensure practical utility. Fourth, strengthen supplier transparency and tariff-risk management by implementing traceability protocols for raw materials and by engaging in forward-looking sourcing agreements that include contingency clauses and alternative supplier networks.

Fifth, enhance commercial models by offering bundled services-technical onboarding, inventory management, and customized documentation-to institutional customers that require predictable supply and regulatory support. Finally, embed sustainability and waste-reduction practices into product design and packaging to meet growing environmental expectations from healthcare procurement organizations and to differentiate on corporate responsibility dimensions.

This research synthesizes primary and secondary methodologies to generate rigorous, actionable insights on peripheral blood separation tubes. Primary research incorporated structured interviews and validation discussions with a cross-section of stakeholders, including clinical laboratory directors, blood bank managers, procurement specialists, research scientists, and technical leads at manufacturing and distribution firms. These engagements focused on use-case requirements, procurement decision drivers, operational pain points, and preferences for product attributes such as anticoagulant chemistry, separator type, and compatibility with automation.

Secondary research included a systematic review of peer-reviewed literature, regulatory guidance documents, manufacturer technical data sheets, and clinical procedure standards to triangulate product performance characteristics and regulatory expectations. Where applicable, public filings and quality system documentation were used to corroborate manufacturing capabilities and compliance practices. Data synthesis emphasized qualitative validation and trend identification rather than numerical estimation, ensuring that conclusions reflect practical constraints and emergent industry behaviors.

Analytical frameworks employed include segmentation mapping by end user, product type, application, technology, and distribution channel, along with supply chain risk matrices and regulatory readiness assessments. Findings were validated through an iterative process of expert review and cross-referencing with clinical practice patterns to ensure relevance and applicability for strategic decision-making.

Synthesis of strategic imperatives emphasizing validated clinical value, operational agility, and regulatory alignment for sustainable competitiveness

Peripheral blood separation tubes occupy a pivotal position at the intersection of laboratory operations, clinical decision-making, and translational research. The combined pressures of technological innovation, changing clinical workflows, and evolving trade and regulatory environments have elevated pre-analytical devices from commodity status to strategic assets in diagnostic and therapeutic pathways. Institutions are increasingly selective, favoring suppliers that demonstrate validated performance, regulatory competence, and supply chain resilience.

Looking across end users, product formats, and technologies, it is evident that differentiation will come from delivering demonstrable clinical value, enabling automation, and supporting specialized applications such as cell therapy and decentralized testing. Operational agility-manifested through regional manufacturing, transparent sourcing, and robust post-market support-will be a key determinant of long-term supplier credibility. Firms that align product development with documented clinical needs and that invest in partnerships for validation are likely to secure preferential procurement from hospitals, diagnostic labs, blood banks, point-of-care centers, and research institutes.

In conclusion, the trajectory for peripheral blood separation tubes favors quality-driven innovation and strategic supply management. Organizations that proactively address regulatory compliance, clinical integration, and tariff-related supply vulnerabilities will be better positioned to capture the strategic value of this essential pre-analytical category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Blood Separation Tube Market, by Product Type

  • 8.1. ACD Tubes
    • 8.1.1. ACD-A Tubes
    • 8.1.2. ACD-B Tubes
  • 8.2. Citrate Tubes
    • 8.2.1. Sodium Citrate Tubes
    • 8.2.2. Trisodium Citrate Tubes
  • 8.3. Edta Tubes
    • 8.3.1. K2 Edta Tubes
    • 8.3.2. K3 Edta Tubes
  • 8.4. Heparin Tubes
    • 8.4.1. Lithium Heparin Tubes
    • 8.4.2. Sodium Heparin Tubes
  • 8.5. Oxalate Tubes
    • 8.5.1. Potassium Oxalate Tubes
    • 8.5.2. Sodium Oxalate Tubes

9. Peripheral Blood Separation Tube Market, by Technology

  • 9.1. Density Gradient Centrifugation
  • 9.2. Gel Separator Tubes
  • 9.3. Membrane Separator Tubes
  • 9.4. Microfluidic Separation

10. Peripheral Blood Separation Tube Market, by Application

  • 10.1. Blood Banking
  • 10.2. Cell Therapy
  • 10.3. Clinical Diagnostics
  • 10.4. Research

11. Peripheral Blood Separation Tube Market, by End User

  • 11.1. Blood Banks
    • 11.1.1. Private Blood Banks
    • 11.1.2. Public Blood Banks
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Hospital-Based Labs
    • 11.2.2. Independent Labs
  • 11.3. Hospitals
    • 11.3.1. Clinics
    • 11.3.2. Secondary Care Hospitals
    • 11.3.3. Tertiary Care Hospitals
  • 11.4. Point-Of-Care Testing Centers
    • 11.4.1. Mobile Testing Units
    • 11.4.2. On-Site Testing Centers
  • 11.5. Research Institutes
    • 11.5.1. Academic Research
    • 11.5.2. Pharma Research

12. Peripheral Blood Separation Tube Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peripheral Blood Separation Tube Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peripheral Blood Separation Tube Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peripheral Blood Separation Tube Market

16. China Peripheral Blood Separation Tube Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AdvaCare Pharma
  • 17.6. Becton, Dickinson & Company
  • 17.7. Biosigma S.p.A.
  • 17.8. Cardinal Health, Inc.
  • 17.9. CML BIOTECH LIMITED
  • 17.10. FL Medical S.R.L.
  • 17.11. Greiner Bio-One International GmbH
  • 17.12. Haemonetics Corporation
  • 17.13. Medtronic plc
  • 17.14. Merck KGaA
  • 17.15. Narang Medical Limited
  • 17.16. Nipro Medical Corporation
  • 17.17. QIAGEN N.V.
  • 17.18. SARSTEDT AG & Co. KG
  • 17.19. Sekisui Chemical Co., Ltd.
  • 17.20. Terumo Corporation
  • 17.21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-A TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-A TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-A TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-B TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-B TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD-B TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM CITRATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM CITRATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM CITRATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TRISODIUM CITRATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TRISODIUM CITRATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TRISODIUM CITRATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K2 EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K2 EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K2 EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K3 EDTA TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K3 EDTA TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY K3 EDTA TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POTASSIUM OXALATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POTASSIUM OXALATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POTASSIUM OXALATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM OXALATE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM OXALATE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SODIUM OXALATE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GEL SEPARATOR TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GEL SEPARATOR TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GEL SEPARATOR TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MEMBRANE SEPARATOR TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MEMBRANE SEPARATOR TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MEMBRANE SEPARATOR TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MICROFLUIDIC SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MICROFLUIDIC SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MICROFLUIDIC SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRIVATE BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRIVATE BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRIVATE BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PUBLIC BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PUBLIC BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PUBLIC BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITAL-BASED LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITAL-BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITAL-BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MOBILE TESTING UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MOBILE TESTING UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY MOBILE TESTING UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ON-SITE TESTING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ON-SITE TESTING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ON-SITE TESTING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PHARMA RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PHARMA RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PHARMA RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBES, 2018-2032 (USD MILLION)
  • TABLE 273. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY CITRATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 274. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY EDTA TUBES, 2018-2032 (USD MILLION)
  • TABLE 275. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HEPARIN TUBES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY OXALATE TUBES, 2018-2032 (USD MILLION)
  • TABLE 277. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 282. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY POINT-OF-CARE TESTING CENTERS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION PERIPHERAL BLOOD SEPARATION TUBE MARKET SIZE, BY ACD TUBE